Sarepta Therapeutics SRPT paid Tarplin, Downs & Young $80K for lobbying in Q4 2024 · Budget, Health Issues and 1 more issue

Trade details

Type: Lobbying report
Amount: $80,000
Quarter: Q4 2024
Stock: Sarepta Therapeutics SRPT
Client: Sarepta Therapeutics
Reported: 25/01/21

Up 0.0% from last quarter

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

Sarepta Therapeutics's other lobbying reports

Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1